2
4
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Antibodies
Antibodies

Immune hemolytic anemia
Definition:
Immune hemolytic anemia is a disorder characterized by anemia due to premature destruction of red blood cells by the immune system.

Alternative Names:
Anemia - immune hemolytic

Causes, incidence, and risk factors:

Immune hemolytic anemia occurs when antibodies form against the body's own red blood cells. The antibodies may be acquired by blood transfusion, pregnancy (if the baby's blood type is different from the mother's), as a complication of another disease, or from a reaction to medications.

If the cause of antibody formation is disease or medication, it is referred to as secondary immune hemolytic anemia. The antibodies will destroy the blood cells because they are recognized as foreign substances within the body.

The cause may also be unknown, as in idiopathic autoimmune hemolytic anemia, which accounts for one-half of all immune hemolytic anemias. The onset of the disease may be quite rapid and very serious, or it may remain mild and not require specific therapy. Risk factors are related to the causes.

Symptoms:
Signs and tests:
Treatment:
Treatment with prednisone is the first therapy that is tried. If prednisone does not improve the condition, a splenectomy (removal of the spleen) may be considered. Immunosuppressive therapy will be given if the person does not respond to prednisone and splenectomy.

Blood transfusions are given with caution, if indicated for severe anemia because of the potential that blood may not be compatible and it may precipitate a reaction.
Expectations (prognosis):
In most people, steroids or splenectomy control anemia. In others, partial control of the anemia is usually achieved.
Complications:
Death rarely occurs from severe anemia. Overwhelming infection may occur as a complication of therapy with steroids or splenectomy, since they reduce the body's ability to fight infection.
Calling your health care provider:
Call your health care provider if unexplained fatigue or chest pain occurs, or if signs of infection are present.
Prevention:
Screening for antibodies in donated blood and in the recipient may prevent hemolytic anemia related to blood transfusions.
Review Date: 10/8/2001
Reviewed By: Rebecca Elstrom, M.D., University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com